Bay Area commuters get free rides Tuesday morning due to Clipper card outage
"ATTENTION: The Clipper system is experiencing an outage on all operators this morning," the Bay Area Clipper account wrote in a post on X. "Please be prepared to pay your fare with another form of payment if required by your transit agency."
Many buses were waving commuters on without asking for payment, and at Bay Area Rapid Transit (BART) train stations, the faregates were open, allowing travelers to walk through for free.
Clipper is owned by the Metropolitan Transportation Commission, which manages transportation for the nine-county Bay Area. The service is used by hundreds of thousands of tech workers in San Francisco and Silicon Valley.
The MTC website said there were 1.35 million unique Clipper cards — physical and digital — used in May, the highest monthly toll for the year and the most since December 2019, before the pandemic. A fact sheet from the MTC says Clipper is used by 800,000 transit riders a day across the region.
BART, in particular, has undergone dramatic changes in recent years, most notably installing fare gates starting in late 2023, with full deployment expected to be completed by the end of this year.
In the first five months of the year, average BART station exits totaled between 170,000 and 182,000 a month, according to its website. Those numbers are way down from the pre-pandemic days of 2019, when averages were generally above 400,000 a month.
The MTC has plans to roll out an updated system called Clipper 2.0, which it says will be a "customer-focused, cost-effective fare collection system" with a "flexible platform for future fare structures." Features include use across the various mobile operating systems, updated communication and "expanded retail, online and mobile sales."
The update, however, has been routinely delayed, leading to tense confrontations at recent Clipper executive board meetings.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
3 days ago
- CNBC
Bay Area commuters get free rides Tuesday morning due to Clipper card outage
Commuters in and around San Francisco rode into work for free on Tuesday morning due to an outage in the Clipper card system, which is used to handle payments for train, bus and ferry rides. "ATTENTION: The Clipper system is experiencing an outage on all operators this morning," the Bay Area Clipper account wrote in a post on X. "Please be prepared to pay your fare with another form of payment if required by your transit agency." Many buses were waving commuters on without asking for payment, and at Bay Area Rapid Transit (BART) train stations, the faregates were open, allowing travelers to walk through for free. Clipper is owned by the Metropolitan Transportation Commission, which manages transportation for the nine-county Bay Area. The service is used by hundreds of thousands of tech workers in San Francisco and Silicon Valley. The MTC website said there were 1.35 million unique Clipper cards — physical and digital — used in May, the highest monthly toll for the year and the most since December 2019, before the pandemic. A fact sheet from the MTC says Clipper is used by 800,000 transit riders a day across the region. BART, in particular, has undergone dramatic changes in recent years, most notably installing fare gates starting in late 2023, with full deployment expected to be completed by the end of this year. In the first five months of the year, average BART station exits totaled between 170,000 and 182,000 a month, according to its website. Those numbers are way down from the pre-pandemic days of 2019, when averages were generally above 400,000 a month. The MTC has plans to roll out an updated system called Clipper 2.0, which it says will be a "customer-focused, cost-effective fare collection system" with a "flexible platform for future fare structures." Features include use across the various mobile operating systems, updated communication and "expanded retail, online and mobile sales." The update, however, has been routinely delayed, leading to tense confrontations at recent Clipper executive board meetings.
CBS News
3 days ago
- CBS News
Clipper Card system outage impacting transit systems throughout Bay Area
Bay Area transportation officials announced Tuesday that the Clipper Card system is experiencing outages, impacting commuters throughout the region. The Metropolitan Transportation Commission, which operates the system, confirmed on social media that the system is out on all transit operators as of 7:15 a.m. ATTENTION: The Clipper system is experiencing an outage on all operators this morning. Please be prepared to pay your fare with another form of payment if required by your transit agency. — Bay Area Clipper (@BayAreaClipper) July 1, 2025 At the Embarcadero BART station in San Francisco, the fare gates were opened as commuters were unable to use their cards. Officials with Caltrain and Muni reported similar issues. Clipper Card officials did not provide an estimate on when the system would be restored. Tuesday's outage comes as several transit agencies, including AC Transit, Caltrain, Muni and the San Francisco Bay Ferry, were implementing fare increases. This is a breaking news update. More details to come.
Yahoo
29-05-2025
- Yahoo
CraniUS Therapeutics Awarded Maryland Tech Council's "2025 Emerging Life Sciences Company of the Year"
BALTIMORE, May 29, 2025 /PRNewswire/ -- CraniUS Therapeutics, a cutting-edge medical device company advancing intracranial drug delivery, is proud to announce it has been voted the "2025 Emerging Life Sciences Company of the Year" by the Maryland Tech Council (MTC). The honor was presented during the Council's prestigious Industry Awards Celebration, which drew over 600 attendees, and recognizes the state's most innovative and impactful companies in technology and life sciences. The company's Founder and Executive Chairman, Dr. Chad Gordon, is a leader in Neuroplastic and Reconstructive Surgery. He serves as Section Chief and Fellowship Program Director at Johns Hopkins School of Medicine. Over his career, Dr. Gordon has secured 21 patents, led three successful venture exits, and conducted three first-in-human studies evaluating advanced cranial implants. His invention of the NeuroPASS™ device—CraniUS's core innovation—sparked the company's formation. This award acknowledges CraniUS's leadership and its groundbreaking development of the NeuroPASS™ platform, which enables direct, reliable delivery of therapeutics to the brain—addressing one of the most persistent challenges in treating brain tumors and other neurological conditions. "We are honored to be recognized by the Maryland Tech Council with this year's Emerging Company Award," said Dr. Gordon. "This milestone reflects not only the dedication of our entire team but also the urgent need for transformative solutions in neurotherapeutics. We are extremely proud to be pioneering the new field of functional neurocranial implants inspired by Neuroplastic Surgery and driving this critical work forward—from right here in Maryland." Mike Maglin, CEO of CraniUS Therapeutics, added, "This award is a testament to the meaningful progress we've made and the momentum we've built—spanning scientific innovation, strategic alliances, and investor engagement. We remain committed to redefining how patients with neurological diseases receive life-changing medicines." The Industry Awards Celebration is Maryland's premier event honoring excellence in technology, life sciences, and innovation. CraniUS was selected from a competitive field of nominees for its rapid growth, strong leadership, and the promise of its revolutionary device platform—employing patented neurotechnology—designed to reshape treatment approaches for conditions such as neurodegenerative diseases, movement disorders, and aggressive brain cancers. About CraniUS TherapeuticsCraniUS Therapeutics is a neurotechnology company developing the first fully implantable platform to bypass the blood-brain barrier for long-term, programmable drug delivery. Its flagship device, NeuroPASS™, is designed to transform the treatment landscape for debilitating neurological conditions across multiple disease types. CraniUS Therapeutics is headquartered in Baltimore, Maryland, and collaborates globally with industry leading experts in neurosurgery, drug delivery, implant design, device engineering, and manufacturing. Media Contact:Elizabeth A. Dale, EdDExecutive Advisor, CraniUS Therapeuticsedale@ View original content to download multimedia: SOURCE CraniUS Therapeutics Melden Sie sich an, um Ihr Portfolio aufzurufen.
